Health

Results: 2797-2808 of 8214

Axovia Therapeutics Unveils New Preclinical Data for AXV-201, for Treatment of Genetic Obesity Caused by MC4R Mutations, at ASGCT

PR Newswire associated0

Bridge to Life Announces Abstract Presentations at The 2025 International Congress of the International Liver Transplantation Society (ILTS) in Singapore, May 28-31, 2025

NHS leaders face both ‘carrot and stick’ in new performance drive

Eisai projects Leqembi® revenue to total JPY 76.5 billion for fiscal year 2025 (April 2025 - March 2026)

PR Newswire associated0

STEERLife Redefines Potent Drug Development with Clean, Green, Continuous Processing

Inside information: Sarah van Hellenberg Hubar-Fisher appointed interim CEO of Bioretec

Guelph General Hospital adds digital pathology to cloud service from Sectra--enables integrated diagnostics for improved patient care

Business Wire logo

AviadoBio Announces ASPIRE-FTD Phase 1/2 Clinical Trial in the UK at Cambridge University Hospitals NHS Foundation Trust, Cardiff and Vale University Health Board, and University College London

Tsingke Showcases at AACR 2025 -- Advancing Global Cancer Research with Integrated Synthesis Solutions

Bioretec Ltd´s business review Q1 2025: Strong net sales in the first quarter; CE approval with comprehensive indications received in January accelerates the future expansion of RemeOs products

71.4% of MetaXplore™ reports from 4,616 patients identified actionable results

Microba Announces Landmark GI Study Results From Over 4,600 Patients

Image created by Clara Leibenguth for Stanford University; featured on cover of May 2025 issue of Nature Neuroscience.

Rubedo Life Sciences’ Drug Discovery Platform, ALEMBIC™, Helps Identify Senescent or “Zombie” Neurons in New Study Linking Neuropathic Pain and Aging Published in Peer-Reviewed Scientific Journal Nature Neuroscience